1,3,7,9-tetramethyluric acid has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Baek, SH; Jung, SH; Ko, JH; Nam, D; Yang, MH | 1 |
| Gao, M; Huang, Q; Huang, Z; Zheng, C; Zheng, J | 1 |
2 other study(ies) available for 1,3,7,9-tetramethyluric acid and transforming growth factor beta
| Article | Year |
|---|---|
Theacrine attenuates epithelial mesenchymal transition in human breast cancer MDA-MB-231 cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Female; Fibronectins; Humans; Nuclear Proteins; Snail Family Transcription Factors; Transforming Growth Factor beta; Twist-Related Protein 1; Uric Acid; Vimentin | 2019 |
Theacrine alleviates chronic inflammation by enhancing TGF-β-mediated shifts via TGF-β/SMAD pathway in Freund's incomplete adjuvant-induced rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Chronic Disease; Freund's Adjuvant; Inflammation; Joints; Lipids; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Uric Acid | 2020 |